Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > News > MIV Therapeutics Inc.'s HAp Nano Stent Coating

March 8th, 2005

MIV Therapeutics Inc.'s HAp Nano Stent Coating

Abstract:
MIV Therapeutics Inc., a developer of next-generation drug-eluting coatings that inhibit the rejection of implanted medical devices, announced today the successful completion of pilot preclinical studies of hydroxyapatite (HAp) coated stents in pig coronary arteries.

Source:
businesswire

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Nanoliposomes Help Efforts to Cure Bacterial Infections January 27th, 2015

Stomach acid-powered micromotors get their first test in a living animal January 27th, 2015

Engineering self-assembling amyloid fibers January 26th, 2015

Promising use of nanodiamonds in delivering cancer drug to kill cancer stem cells: NUS study shows that delivery of Epirubicin by nanodiamonds resulted in a normally lethal dosage of Epirubicin becoming a safe and effective dosage for treatment of liver cancer January 26th, 2015

Announcements

JPK opens new expanded offices in Berlin to meet the growing demand for products worldwide January 28th, 2015

Carbon nanoballs can greatly contribute to sustainable energy supply January 27th, 2015

The laser pulse that gets shorter all by itself: Ultrashort laser pulses have become an indispensable tool for atomic and molecular research; A new technology makes creating short infrared pulses easy and cheap January 27th, 2015

New pathway to valleytronics January 27th, 2015

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE